Introduction {#s0005}
============

Ribogenomics is the science and knowledge about ribonucleic acid (RNA). As one of the four major macromolecules (percentage weight in mammalian cell: DNA, ∼7 pg, 0.3%; RNA, ∼20 pg, 1%; protein, ∼500 pg, 20%; and polysaccharide, ∼2 μg, 78.7% [@b0005; @b0010]) of cellular life forms, RNA deserves not only a dedicated research field but also definitions of its roles in cellular processes and molecular mechanisms. Therefore, ribogenomics, at least in a sense of cellular mass, in terms of research focus and priority, may not be more imperative than proteomics but certainly has no reason to draw less attention than genomics.

RNA molecules can be divided into two essential functional categories: operational (including what have been defined as catalytic) and informational. At the center of the informational RNAs (other types of informational RNAs including those guiding processes that change mRNA sequences) is messenger RNA (mRNA). In a typical mammalian cell, mRNA takes ∼4% of the total RNA mass and aside from 80% ribosomal RNA (rRNA), other operational RNAs make up the rest. If we take the constitutive RNAs --- transfer RNAs (tRNAs) and rRNAs --- out of the total, the ratio of the operational RNA *vs.* the informational RNA [@b0015; @b0020] is about four.

What are the operational RNA types in the dynamic portion of the total RNA? First, all RNA macromolecules are operational. Only the protein-coding portion of all mRNAs is relatively informational, together with certain sequence-specific guiding RNAs (including small sequence-matching RNAs) that may actually aid RNA editing and splicing, while the chemical entity of them remains operational. Second, all non-coding RNAs (ncRNAs) are exclusively operational, including mRNA-like transient transcripts that are often generated from gene duplications --- genome-wide, segmental or individual --- but may not be translated into functional proteins [@b0025; @b0030; @b0035]. Transcripts of such kind have been confusing as some of them neither are conserved across closely-related species nor contain normal reading frames albeit often polyadenylated [@b0040; @b0045]. Third, all small RNAs (sRNAs), such as microRNAs (miRNAs), small nuclear RNAs (snRNAs), tRNA-derived sRNAs (tsRNAs), small nucleolar RNAs (snoRNAs) and small interfering RNAs (siRNAs), are operational although they may be processed to become functional in different ways [@b0050; @b0055; @b0060]. Fourth, long ncRNAs (lncRNAs), intron-encoded or intergenic sequence-encoded, are also all operational, which may act on different aspects of cellular activities and mechanisms [@b0060]. In this article, we first divide ribogenomes into informational and operational tracks, pointing out the obvious differences and intricate relationships between the two tracks, and then provide insights on the research scopes and fundamental scientific questions of ribogenomics under such a scheme.

Ribogenomics on the operational track {#s0010}
=====================================

Life had started with RNAs [@b0065; @b0070; @b0075]. Molecular mechanisms and cellular processes of the operational ribogenomic track have to be created earlier than those of the informational track until the genetic code was created [@b0080; @b0085; @b0090; @b0095; @b0100]. We have argued before that early RNA-built life forms may have begun as eukaryote-like organisms since simple life forms might not be able to utilize DNA at all initially and bacteria might be too greedy to keep all complicated molecular mechanisms going, such as RNA splicing and polyadenylation [@b0080]. Fundamentally, RNA macromolecules and their intermediates, as well as building blocks, must have performed all essential cellular functions but some may have lost to proteins over evolutionary time scales. Therefore, active searches for the function of various RNA macromolecules should focus on systematic discovery at all levels and for all facets of molecule mechanisms and cellular processes rather than taking the attitude of "guarding the stump for dumb hare to hit on".

Operational RNAs are diverse in function ([Figure 1](#f0005){ref-type="fig"}) as well as in sequence length and genomic origin [@b0060; @b0105]. In function-seeking studies, any effort should include both size classes, large and small, of ncRNAs and choose complementary methods [@b0110; @b0115]. The first level of functional studies is chromosomal structure, conformation and organization as exemplified by the X chromosome inactivation in recent years [@b0120]. A striking recent discovery is the sweeping partition of house-keeping and tissue-specific genes between early and late replicating genes, respectively [@b0125; @b0130]. Aside from the well-known RNA involvement in replication, some sRNAs are also engaged in DNA repair mechanisms, such as DNA double-strand break repair-induced sRNA (diRNA) [@b0135] and tRNA-derived miRNA [@b0140]. The second level to look for RNA-centric regulation is gene-cluster organization that is regulated at multiple levels, such as organization of chromosomal elements or sequence repeats, nucleosome positioning, histone marks, antisense RNAs and transcriptional regulation [@b0145; @b0150; @b0155; @b0160; @b0165]. There have also been many new elements in transcriptional regulation discovered by in-depth transcription level studies [@b0170] and we will be discussing more details in the context of the informational track of ribogenomics. The third level to classify the RNA-centric mechanisms and processes is RNA processing --- splicing-routing-exporting. Routing is a novel concept that proposes a possible function for a particular class of introns --- minimal introns [@b0170; @b0175]. While the minimal intron is universal and stringent in size, the fraction of minimal intron-containing genes appears stable within and across taxonomic scales [@b0180]. Among mammals, about 10% of the total introns are minimal introns, which are shared by one third of the genes [@b0185]. The fourth level concerns the metabolism or stability of RNAs, including integrity surveillance and clearance/degradation, which is related to RNA damage, synthetic error and chemical modification [@b0190]. Finally, RNA modification deserves a new discipline, as it has been proposed as epitranscriptomics [@b0195]. Although it is classified in our scheme as part of the operational ribogenomic track, we have no intention to de-emphasize the importance of RNA modification and its roles in RNA function. However, it does have its own dilemma --- only a minor fraction of the RNA macromolecules and a limited number of nucleotide residues of them are actually modified.

Ribogenomics and its research are still at their infancy --- the discovery phase. Cheering for discovering a new class of sRNAs is only the beginning of a long search for their functions and mechanisms ([Table 1](#t0010){ref-type="table"}). The measurable parameters for components in an operational ribogenomic track are multi-fold. The first parameter is specificity since nucleotide pairing by hybridization provides a powerful apparatus. In addition, the imperfect base pairing leaves opportunities for other protein apparatuses to be engaged. The second parameter is sensitivity that is also chemical in nature. For instance, a miRNA has to overwhelm its mRNA targets in apparent (effective) concentration. It is hard to image how a miRNA with a low copy number, such as dozens, inhibits an mRNA that has hundreds of copies and multiple target sites. Although the relationship between an mRNA target and an inhibitory miRNA may be more complex than what we have anticipated, quantitative studies on both parties are of essence. The third parameter is stability that is usually measured by half-life. RNA degrades very fast in general since the process does not need energy. RNA stability and structural dynamics are known to relate to its post-transcriptional modifications [@b0225; @b0230]. The fourth is the *ad hoc* creation of ncRNAs from a large candidate pool and one of the problems is the fact that a significant fraction of ncRNAs lacks sequence conservation across taxonomic scales [@b0045]. In summary, since operational RNA macromolecules are rather massive in numbers and diverse in functions, our efforts to understand them have to be significant enough.

Ribogenomics on the informational track {#s0015}
=======================================

It may not be easy to define a transcriptome if informational and operational RNAs are not differentiated; the former is largely mRNA that is large and more characteristic, and the latter is largely sRNA together with size-variable ncRNAs. Even protein-coding transcripts are not easily identified when it comes to plants and vertebrates -- whose genomes of different lineages are not only structured differently but also fast-evolving after genome-wide duplication (GWD) [@b0235; @b0240; @b0245; @b0250; @b0255; @b0260; @b0265]. Although mRNAs and their precursors are the only informational RNA class, their evolutionary transients are difficult to be thoroughly defined [@b0025; @b0265].

Classic transcriptomics has been focusing on identification of mRNAs in a given cell type or tissue, often for a comparative analysis. Such a study is based on the assumption that mRNAs dominate the functional content and are relevant to the function and functional changes of a given cell type. For a typical mammalian cell, the estimated mRNA is 1--2 pg in mass, 2 kb on average in length and about 0.5--1 million in number. Based on our theoretical model [@b0270] and estimation on the total number of mRNAs in different cell types [@b0275; @b0280], a transcript-rich cell (such as stem cells and cells from cerebrum and testis) may have as many as 1 million mRNAs whereas a transcript-poor cell (such as various cell lines and epithelial cells) may have only half of the number or 0.5 million ([Table 2](#t0015){ref-type="table"}). Therefore, a deep-sampling strategy allows a reasonable description of a transcriptome and its transcript distribution. Empirically, we acquire over 20 million mapped sequence tags (raw data usually are not good ground for such estimation) for a given transcriptome [@b0285; @b0290; @b0295], regardless what mRNA preparation methods are used [@b0110].

The ultimate goal of an essential transcriptomic effort is to map all transcripts from all cell types of a given organism (species), such as human and mouse for biomedical research. By using the current technical platforms, this goal is not easily fulfilled for the following reasons. First, for a thorough transcript discovery effort, we do not have a series of protocols to purify RNAs of different sizes and copy numbers for consistent library construction. For copy number validation, our current techniques either are too expensive (sequencing) or have poor dynamic range (microarray) in detection so that low-copy transcripts are often lost in the process. Second, a basic sampling of different tissues/organs/cells already significantly exceeds hundreds of libraries [@b0300]. In addition, longitudinal studies can easily add up the libraries to thousands. If diseases and other pathological conditions such as tumors are to be concerned, the libraries for such an endeavour can exceed hundreds of thousands. The cost therefore can easily reach billions. Third, a pilot project to pave a way for a large-scale discovery of mammalian transcriptomes is of essence, where cell and tissue types are well defined. Nevertheless, an effort to map all transcripts in representative mammals and full mapping for humans under various physiological and pathological conditions has to be launched in the near future. Some of the parameters to be defined and theoretical concerns are detailed in [Box 1](#x0005){ref-type="boxed-text"}.Box 1The complexity of defining transcriptomes*Occurrence-definition: universality and specificity*Universal: shared by all tissues/organs/cellsTissue-specific: shared by a single or limited number of tissues (such as nerves, muscles and epithelia)Cell-specific: unique to a single cell typeNear universal: shared by most tissues but not allRationally shared: genes that are shared between unrelated tissues or cell types based on function*Expression-definition: variability and magnitude*Expression-variable (majority; genes vary in expression among tissues)Expression-constant (minority; genes are expressed constantly in all cell types)Highly-expressed (\>1000s of copies)Moderately-expressed (10s−100s of copies)Lowly-expressed (\<10 copies)*Function-informational: gene composition, structure, organization and variation*Size: large (\>500 kb) *vs*. small, median sizeGC/purine content: GC-rich *vs*. GC-poorCpG islands: high, moderate and low densityMinimal-intron-containingBiologically-defined repetitive sequence element associatedGene cluster-associatedTranscript-centric variationGermline-specificPurifying (Ka/Ks \<1) and positively-selected (Ka/Ks \>1) genes*Function-operational: cellular structure, process and mechanism*Mitochondrion-associatedChloroplast-associatedNucleolus-associatedCircadian-regulatedCell cycle-regulatedStem cell-differentiationTranslation machinerySplicing machineryNuclear exporting machinery*Condition-definition*Embryonic developmentEpidermal differentiationPhenotypic plasticity: *e.g*., hibernationPathological conditions*Note:* Ka/Ks indicates the ratio of nonsynonymous to synonymous substitution rates.

Along the informational ribogenomic track, an integrated view of genetics and evolution are also critical. There have been several critical points to be made clear and integrated into the current paradigm. First, we have, in the recent years, discovered a novel phenomenon --- transcript-centric mutations, originally in the rice genome [@b0015; @b0305] and later in all organisms from bacteria to human [@b0125; @b0130; @b0310; @b0315]. The universality of this mutation spectrum is attributed to its underlying mechanism, namely transcription-coupled DNA repair [@b0015; @b0020]. The new mechanism will undoubtedly reset the traditional way of mutation assessment and interpretation. Second, we have also learnt how to differentiate two replication-centric mutations based on a simple partition between house-keeping and tissue-specific genes, where the latter class of genes tends to have ∼30% more mutations than the former class [@b0125]. The mechanism is related to chromosomal structure in which house-keeping genes are organized in such a way that they are always replicated earlier. Further stratification of genes, partition of chromosomes and detailed analysis on population data are all necessary for revealing mechanisms at chromosomal organization and transcriptional levels. Third, distributed along all transcripts, the spectrum of the transcript-centric mutations not only shows a gradient effect when aligned from the transcription starting site but also displays a periodicity reflecting nucleosome-space occupancy [@b0145; @b0320]. We also anticipate more concerns and discoveries on well-defined and confounding factors of inheritable genetic variations.

Acquisition of an organism's transcriptomes and its technical challenges {#s0020}
========================================================================

How could we experimentally define a transcriptome and transcriptomes of an organism? Conceptually, a transcriptome can be defined as all transcripts in a cell type under a defined condition. It includes transcripts of all sizes and essentially two categories of RNA macromolecules: informational and operational RNAs. Alternatively, the two can be categorized into three groups: mRNAs, lncRNAs and small ncRNAs (sncRNAs). Obviously, some of the transcripts are part of protein-coding genes [@b0235] and others are just transcripts or transcribed RNA elements. Since not all transcripts are easily validated for precise functions, novel RNA elements remain a viable group of candidate operational RNAs.

The empirical definition of transcriptomic components in full remains a tough challenge due to several technical hurdles. First, its thorough discovery relies on sequencing technology that is essentially a sampling strategy, involving many parameters such as sample quality and instrument efficiency (*e.g.*, read length, error rate, throughput and per sample cost) [@b0325; @b0330]. Second, experimental protocols are also highly relevant. Although there are endless choices of commercial kits, their reliability and reproducibility remain to be systematically evaluated before large-scale applications. Most delicate of all is sample handling and preparation: RNA quantitation, internal control for cross-library normalization, parallel sampling strategy, appropriate controls, *etc*. Third, a software package needs to be put together for data normalization across libraries, comparative expression analysis, gene annotations and functional classifications. Fourth, implementation and coordination of an international and large-scale effort is also a great challenge. A consortium for International Mammalian Ribogenome Project should be formed first. Different transcriptomic projects as its components should be carefully planned and physicians and clinical researchers are to be involved also to justify the usefulness of each transcriptome to be produced.

One important question remains: can we avoid transcriptomic projects being open-ended? Although the answer is definite, cautions have to be taken seriously. There are good news and bad news for transcriptomic projects. The good news includes unlimited number of projects to be proposed, multiple choices for technical platforms and approaches, and similar data types for centralization and integration. The bad news includes the presence of cellular heterogeneity, unavoidable cross-contamination of cell types/tissues/organs and instability of cellular gene expression. We have to be careful in defining and organizing transcriptome projects in that both real-time and transgenerational measurement are of importance.

Conclusion {#s0025}
==========

For decades into the business of genomics and transcriptomics, we have never before felt the need of systematic data acquisition, rational parameter analysis, and comprehensive understanding of the intricate relationship among pathways and networks of ribogenomics and other macromolecule-centric "omics", including genomics, epigenomics, proteomics and metablomics on a multiple-track system [@b0020]. We do have a long to-be-done list here for the ribogenomic basics: mammalian transcriptomes (development, circadian, seasonal, life span, *etc.*) and human disease transcriptomes (cancers, cardiovascular diseases, metabolic disease, autoimmune diseases, *etc.*). The complexity also comes from both anatomic and longitudinal partitions, let alone the growing catalogue of RNA types. However, "a march of a thousand miles always has to begin with a single step", a large-scale project, in the context of international collaboration and magnitude of the Human Genome Project, is of essence; or maybe multiple projects of the kind are to be organized. The Human Genome Project was proposed about 30 years ago, its profound and unprecedented influence is still alive. If we believe that its legacy should live on and is carried by the current generation of genomicists and ribogenomicists, it is about time to act.
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![**Schematic view from genotype to phenotype with informational and operational tracks**\
Ribogenomics in the context of a genotype-to-genotype view. Genotype becomes one of the deterministic factors that include ribogenomic, epigenomic, homoeostatic, compartmental and plastic tracks. For the sake of discussion, here we simply classify non-coding RNAs (ncRNAs) into small ncRNAs (sncRNAs) and long ncRNAs (lncRNAs). To emphasize the influence of transcript-centric mutations, we identify expression-related simple nucleotide variations (eSNVs) as an important class of sequence variations that are not yet considered in the context of traditional population genetics and evolution.](gr1){#f0005}

###### 

Some informational and operational RNAs summarized in the literature for human, mouse, rice and *Arabidopsis*

  **RNA types**         **Human**         **Mouse**         **Rice**      ***Arabidopsis***   
  --------------------- ----------------- ----------------- ------------- ------------------- -----------------
  *Informational RNA*                                                                         
  mRNA                  130,029           80,383            44,118        30,633              
  guideRNA              210 [@b0200]      NA                NA            NA                  
                                                                                              
  *Operational RNA*                                                                           
  Large                 lncRNA            53,000 [@b0060]   NA            NA                  13,000 [@b0205]
  lincRNA               27,500 [@b0060]   NA                NA            6480 [@b0205]       
  Small                 miRNA [@b0210]    4450              3094          1305                635
  snoRNA                403 [@b0200]      NA                46 [@b0215]   587 [@b0215]        
  piRNA                 114 [@b0220]      2710 [@b0220]     NA            NA                  

*Note:* We do not estimate the number of genes here but merely count the number of mRNAs recorded in the UniGene database (<http://www.ncbi.nlm.nih.gov/unigene/statistics/>). The different numbers of RNAs identified in the databases or publications reflect the incomplete nature of the studies and collections. Only some representative classes of RNAs are listed here. NA, not yet available.

###### 

Distribution of mRNA abundance in different cell types based on a theoretical model

  **mRNA expression level (copies/cell)**   **500 K**   **1000 K**   **5000 K**                 
  ----------------------------------------- ----------- ------------ ------------ ---- -------- ------
  \<1                                       42,665      55           26,977       35   1114     1.40
  1--5                                      22,866      30           31,104       40   25,863   34
  5--10                                     4822        6            7450         10   15,688   20
  10--50                                    5089        6            8415         11   22,866   30
  50--100                                   855         1            1496         2    4822     6.30
  100--500                                  763         1            1421         2    5089     6.60
  \>500                                     92                       289               1710     2.20
  Mean copies per mRNA                      6.48        12.96        64.81                      
  Median copies per mRNA                    0.83        1.66         8.28                       

*Note:* The total number of mRNAs per cell in different cell types is estimated based on our theoretical model or previous studies [@b0270; @b0275; @b0280]. 500 K indicates the total number of mRNA copies in a transcript-rich cell, such as stem cells and cells from cerebrum and testis; 1000 K indicates the total number of mRNA copies in a transcript-poor cell, such as various cell lines and epithelial cells; 5000 K indicates the total number of mRNA copies in a hypothetical cell used for data analysis in this theoretical model [@b0270].
